Literature DB >> 33549114

Protein-protein interaction analysis reveals a novel cancer stem cell related target TMEM17 in colorectal cancer.

Zhao-Liang Yu1,2, Yu-Feng Chen1,2, Feng Gao3,4, Xiao-Jian Wu5,6,7, Bin Zheng2,8, Ze-Rong Cai1,2, Yi-Feng Zou1,2, Jia Ke1,2, Ping Lan1,2,8.   

Abstract

BACKGROUND: Cancer stem cells (CSCs) are a small subpopulation of cells within tumors with stem cell property. Increased evidence suggest that CSCs could be responsible for chemoresistance and recurrence in colorectal cancer (CRC). However, a reliable therapeutic target on CSCs is still lacking.
METHODS: Here we describe a two-step strategy to generate CSC targets with high selectivity for colon stem cell markers, specific proteins that are interacted with CSC markers were selected and subsequently validated in a survival analysis. TMEM17 protein was found and its biological functions in CRC cells were further examined. Finally, we utilized the Gene Set Enrichment Analysis (GSEA) to investigate the potential mechanisms of TMEM17 in CRC.
RESULTS: By combining protein-protein interaction (PPI) database and high-throughput gene profiles, network analysis revealed a cluster of colon CSCs related genes. In the cluster, TMEM17 was identified as a novel CSCs related gene. The results of in-vitro functional study demonstrated that TMEM17 depletion can suppress the proliferation of CRC cells and sensitize CRC cells to chemotherapy drugs. Enrichment analysis revealed that the expression of TMEM17 is associated with the magnitude of activation of the Wnt/β-catenin pathway. Further validation in clinical samples demonstrated that the TMEM17 expression was much higher in tumor than normal tissue and was associated with poor survival in CRC patients.
CONCLUSION: Collectively, our finding unveils the critical role of TMEM17 in CRC and TMEM17 could be a potential effective therapeutic target for tumor recurrence and chemoresistance in the colorectal cancer (CRC).

Entities:  

Keywords:  Cancer stem cell; Chemoresistance; Colorectal cancer; Protein–protein interaction; TMEM17

Year:  2021        PMID: 33549114      PMCID: PMC7868027          DOI: 10.1186/s12935-021-01794-2

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  41 in total

1.  TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence.

Authors:  Isabel Puig; Stephan P Tenbaum; Irene Chicote; Oriol Arqués; Jordi Martínez-Quintanilla; Estefania Cuesta-Borrás; Lorena Ramírez; Pilar Gonzalo; Atenea Soto; Susana Aguilar; Cristina Eguizabal; Ginevra Caratù; Aleix Prat; Guillem Argilés; Stefania Landolfi; Oriol Casanovas; Violeta Serra; Alberto Villanueva; Alicia G Arroyo; Luigi Terracciano; Paolo Nuciforo; Joan Seoane; Juan A Recio; Ana Vivancos; Rodrigo Dienstmann; Josep Tabernero; Héctor G Palmer
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

2.  Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.

Authors:  Julien Taieb; Hampig Raphael Kourie; Jean-François Emile; Karine Le Malicot; Ralyath Balogoun; Josep Tabernero; Enrico Mini; Gunnar Folprecht; Jean-Luc Van Laethem; Claire Mulot; Olivier Bouché; Thomas Aparicio; Pierre Michel; Josef Thaler; John Bridgewater; Eric Van Cutsem; Géraldine Perkins; Come Lepage; Ramon Salazar; Pierre Laurent-Puig
Journal:  JAMA Oncol       Date:  2018-07-12       Impact factor: 31.777

Review 3.  Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process.

Authors:  Sébastien Marx; Thomas Dal Maso; Jia-Wei Chen; Marina Bury; Johan Wouters; Carine Michiels; Benjamin Le Calvé
Journal:  Semin Cancer Biol       Date:  2019-08-24       Impact factor: 15.707

4.  A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.

Authors:  Felipe de Sousa e Melo; Antonina V Kurtova; Jonathan M Harnoss; Noelyn Kljavin; Joerg D Hoeck; Jeffrey Hung; Jeffrey Eastham Anderson; Elaine E Storm; Zora Modrusan; Hartmut Koeppen; Gerrit J P Dijkgraaf; Robert Piskol; Frederic J de Sauvage
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

Review 5.  Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.

Authors:  Jose J G Marin; Fermin Sanchez de Medina; Beatriz Castaño; Luis Bujanda; Marta R Romero; Olga Martinez-Augustin; Rosario Del Moral-Avila; Oscar Briz
Journal:  Drug Metab Rev       Date:  2012-05       Impact factor: 4.518

6.  Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.

Authors:  D D Fang; Y J Kim; C N Lee; S Aggarwal; K McKinnon; D Mesmer; J Norton; C E Birse; T He; S M Ruben; P A Moore
Journal:  Br J Cancer       Date:  2010-03-23       Impact factor: 7.640

7.  Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.

Authors:  L Vermeulen; M Todaro; F de Sousa Mello; M R Sprick; K Kemper; M Perez Alea; D J Richel; G Stassi; J P Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

Review 8.  IL-4-mediated drug resistance in colon cancer stem cells.

Authors:  Matilde Todaro; Mileidys Perez Alea; Alessandro Scopelliti; Jan Paul Medema; Giorgio Stassi
Journal:  Cell Cycle       Date:  2007-11-30       Impact factor: 4.534

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

10.  Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.

Authors:  Guang-Yuh Chiou; Tzu-Wei Yang; Chi-Chou Huang; Chia-Ying Tang; Jung-Yi Yen; Ming-Chang Tsai; Hsuan-Yi Chen; Nurul Fadhilah; Chun-Che Lin; Yuh-Jyh Jong
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

View more
  1 in total

1.  Correction to: Protein-protein interaction analysis reveals a novel cancer stem cell related target TMEM17 in colorectal cancer.

Authors:  Zhao-Liang Yu; Yu-Feng Chen; Bin Zheng; Ze-Rong Cai; Yi-Feng Zou; Jia Ke; Ping Lan; Feng Gao; Xiao-Jian Wu
Journal:  Cancer Cell Int       Date:  2021-03-18       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.